Authorization

Point of Care Molecular Diagnostics Market revenue to cross USD 2.8 Bn by 2026: Global Market Insights, Inc.

Selbyville, Delaware, Sept. 21, 2020 (GLOBE NEWSWIRE) --
According to latest report a??PoC Molecular Diagnostics Market by Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhea, Chlamydia, Hepatitis C, Hepatitis B}, Oncology, Hematology), End-use (Hospitals, Clinics), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026a??, by Global Market Insights, Inc., the market valuation of point of care (PoC) molecular diagnostics will cross $2.8 billion by 2026. Strategic initiatives for developing innovative PoC molecular diagnostics assays and instruments will accelerate the market growth.Point of care molecular diagnostics tests deliver several benefits from enhancing patient care to limiting healthcare expenditure. High-quality diagnostic tests are widely available in developed countries, while developing economies face a shortage of high-quality diagnostic tools. Therefore, there is a rise in R&D investment by public and private organizations for delivering cost-effective and high-quality diagnostic tools to satisfy the growing consumer demand in developing countries of the Asia Pacific and Latin America. Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2210
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Октябрь 2020    »
ПнВтСрЧтПтСбВс
 1234
567891011
12131415161718
19202122232425
262728293031